Time to progression to castration-resistant prostate cancer after commencing combined androgen blockade for advanced hormone-sensitive prostate cancer

PURPOSE: The aim of our retrospective study was to determine the time to progression to castration-resistant prostate cancer (CRPC) in prostate cancer patients who undergo combined androgen blockade (CAB), as well as their prognoses. MATERIALS AND METHODS: We examined the overall survival (OS) and d...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Tamada, Satoshi, Iguchi, Taro, Kato, Minoru, Asakawa, Jumpei, Kita, Kazuaki, Yasuda, Sayaka, Yamasaki, Takeshi, Matsuoka, Yudai, Yamaguchi, Kazuyuki, Matsumura, Kentaro, Go, Ishun, Ohmachi, Tetsuji, Nakatani, Tatsuya
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2018
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6319345/
https://ncbi.nlm.nih.gov/pubmed/30651928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26426
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы